Zestril Shortage: What Providers and Prescribers Need to Know in 2026

As a prescriber, you may be hearing from patients who are struggling to fill their lisinopril (Zestril) prescriptions. While lisinopril is not currently on the FDA Drug Shortage database as of 2026, manufacturer-level discontinuations and distribution shifts have created localized availability gaps that directly affect your patients. This briefing covers the current landscape, prescribing implications, and actionable strategies for maintaining continuity of care.

Current Supply Situation (2026)

Lisinopril is not on the FDA Drug Shortages database as of 2026. However, ASHP has flagged that Teva temporarily discontinued lisinopril tablets and Lupin Pharmaceuticals discontinued multiple bottle-count configurations. Active suppliers include Exelan Pharmaceuticals, Lupin (some formulations), and Major Pharmaceuticals.

The distribution landscape in 2026:

• Chain pharmacies: May experience intermittent stock-outs due to single-distributor contracts and allocation limits. CVS, Walgreens, and Rite Aid are most frequently affected by manufacturer-specific disruptions.
• Independent pharmacies: Generally better access through relationships with multiple wholesalers (McKesson, Cardinal Health, AmerisourceBergen). Often the first resource to try when chains are out.
• Warehouse stores: Costco and Sam's Club maintain larger bulk inventories and are less affected by single-distributor issues.
• Mail-order pharmacies: Express Scripts, OptumRx, and CVS Caremark mail facilities maintain larger inventories and are rarely affected by retail-level shortfalls.

Clinical Implications of Lisinopril Gaps

For patients taking lisinopril for hypertension, a brief gap of 1-3 days is unlikely to cause a hypertensive crisis in most patients, though blood pressure should be monitored. For higher-risk populations, even brief interruptions carry greater risk:

• Post-MI patients: ACE inhibitor therapy is critical in the first 30 days post-infarction and beyond. Interruption can increase risk of remodeling and mortality. Prioritize continuity of care.
• Heart failure patients: ACE inhibitor therapy reduces mortality and hospitalizations. Abrupt discontinuation can lead to hemodynamic decompensation.
• Diabetic nephropathy patients: ACE inhibitors provide renoprotective effects beyond blood pressure reduction. Interruption may accelerate proteinuria.

Therapeutic Alternatives: ACE Inhibitor Dose Equivalences

When switching to another ACE inhibitor, approximate dose equivalences are:

• Lisinopril 10 mg ≈ Enalapril 10 mg (twice daily) ≈ Ramipril 5 mg (once or twice daily) ≈ Benazepril 10-20 mg (once or twice daily)
• Lisinopril 20 mg ≈ Enalapril 20 mg (twice daily) ≈ Ramipril 10 mg ≈ Benazepril 20-40 mg

Note: These are approximate equivalences. Titrate based on blood pressure response and renal/potassium monitoring within 1-2 weeks of switching.

Switching to ARBs: When ACE Inhibitors Are Unavailable

If all ACE inhibitors are unavailable or if the patient has ACE inhibitor-induced cough, ARBs are the appropriate class alternative:

• Losartan (Cozaar) — 50-100 mg daily for hypertension, available as inexpensive generic
• Valsartan (Diovan) — 80-320 mg daily, well-established in heart failure
• Candesartan (Atacand) — 16-32 mg daily, used in heart failure with reduced ejection fraction

Monitor BP, potassium, and serum creatinine 1-2 weeks post-switch, particularly in patients with CKD, heart failure, or diabetes.

41,566+ patients found their medications in stock

41K+

Find Zestril In Stock Today →

Patient Counseling Recommendations

Advise patients to:

• Refill prescriptions 7-10 days early when possible
• Try independent pharmacies or warehouse stores if chain pharmacies are out
• Use medfinder.com to locate nearby pharmacies with their medication in stock
• Never abruptly stop lisinopril without consulting their provider

Tools for Providers

medfinder for Providers (medfinder.com/providers) allows your clinical staff to quickly locate pharmacies with lisinopril in stock for patients. Instead of patients making repeated calls, medfinder contacts pharmacies on their behalf and delivers results by text.